Prism Medico and Pharmacy Ltd
Prism Medico and Pharmacy Ltd (PRISMMEDI) last traded at ₹30.3, a market capitalisation of ₹41.1 crore. Over the past 52 weeks the stock has ranged between ₹15.5 and ₹34.5. Prism Medico and Pharmacy Ltd last reported results for the quarter ended Dec 2019, with sales of ₹9.75 crore and net profit of ₹-0.04 crore. Prism Medico and Pharmacy Ltd’s annual general meeting is scheduled for 19 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Prism Medico and Pharmacy Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Prism Medico and Pharmacy Ltd quarterly results
In the quarter ended Dec 2019, sales were ₹9.75 cr, down 43.1% from ₹17.13 cr a year earlier. Net profit swung to a loss of ₹0.04 cr.
| ₹ crore | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0.36 | 5.78 | 15 | 17.13 | 16.8 | 8.71 | 6.63 | 9.75 |
| Expenses | 0.54 | 5.35 | 14.68 | 16.89 | 17.39 | 8.54 | 6.39 | 9.75 |
| Operating profit | -0.25 | 0.42 | 0.29 | 0.21 | -0.63 | 0.17 | 0.17 | -0.07 |
| OPM % | -69.44% | 7.27% | 1.93% | 1.23% | -3.75% | 1.95% | 2.56% | -0.72% |
| Other income | 0.03 | 0.05 | 0.05 | 0 | 0.05 | 0 | 0 | 0.03 |
| Interest | 0.07 | 0.01 | 0.03 | 0.03 | 0.04 | 0 | 0.07 | 0.07 |
| Depreciation | 0.13 | 0.09 | 0.07 | 0.07 | 0.15 | 0.09 | 0.09 | 0 |
| Profit before tax | -0.35 | 0.38 | 0.27 | 0.14 | -0.73 | 0.08 | 0.08 | -0.04 |
| Tax % | 20.00% | 0.00% | 0.00% | 0.00% | 0.00% | -62.50% | -12.50% | 0.00% |
| Net profit | -0.42 | 0.37 | 0.28 | 0.15 | -0.73 | 0.13 | 0.09 | -0.04 |
| EPS (₹) | -0.69 | 0.61 | 0.46 | 0.25 | -1.20 | 0.21 | 0.15 | -0.07 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Prism Medico and Pharmacy Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | TTM |
|---|---|---|---|---|
| Sales | 5.27 | 22.78 | 54.43 | 41.89 |
| Operating profit | -0.08 | 0.54 | 0.22 | -0.36 |
| OPM % | -1.52% | 2.37% | 0.40% | -0.86% |
| Net profit | -0.22 | 0 | 0.04 | -0.55 |
| EPS (₹) | -0.36 | 0.00 | 0.07 | -0.91 |
TTM is the trailing twelve months to the most recent quarter.
Prism Medico and Pharmacy Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 9%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -245%
- 10 Years
- 2%
- 5 Years
- 44%
- 3 Years
- 5%
- 1 Year
- 48%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 0%
- Last Year
- 1%
Prism Medico and Pharmacy Ltd shareholding pattern
Promoters held 29.98% at Jun 2026, up from 25.00% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | 25.50% | 29.98% |
| Public | 74.99% | 75.00% | 74.99% | 75.00% | 75.00% | 75.01% | 74.51% | 70.02% |
| No. of shareholders | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 | 4,295 | 4,177 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Prism Medico and Pharmacy Ltd’s AGM?
Prism Medico and Pharmacy Ltd’s annual general meeting is scheduled for 19 Sept 2026.
- AGM24th Annual General Meeting and related procedural resolutions
See the full results calendar for every Indian company reporting in the next 30 days.
Prism Medico and Pharmacy Ltd corporate filings
- Dear Sir/ Madam, Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ....Corp. Actionlow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has issued an intimation regarding the record date for its…
Read the full analysis - Dear Sir/Madam, Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March, 2026. You are requested ....Corp. Actionlow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has issued an intimation regarding the book closure for its…
Read the full analysis - Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....Company Updatelow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has submitted its Annual Report for the financial year…
Read the full analysis - Dear Sir/ Madam, Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith ....Company Updatelow impact
Cruxal's analysis: Prism Medico and Pharmacy Ltd has submitted its Annual Report for the financial year…
Read the full analysis - Dear Sir/Madam, The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September, 2026 through VC/OAVM. The notice of the same is attached ....AGM/EGMhigh impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has announced a major shift in its capital allocation…
Read the full analysis - 1. Considered & approved: (i) Director''s Report for the F.Y. ended March 31, 2026 (ii) notice of 24th AGM to be held on September 19, 2026 at 12:30 P.M. through VC/OAVM 2. Fixed date ....Board Meetingmedium impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has scheduled its 24th Annual General Meeting for…
Read the full analysis - Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 ,inter alia, to consider and approve ? To consider and ....Board Meetinglow impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has issued a formal intimation regarding a Board…
Read the full analysis - Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held ....Board Meetingmedium impact
Cruxal's analysis: Prism Medico and Pharmacy Limited reported a net loss of 5.83 lakh for the quarter ended…
Read the full analysis - Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....Board Meetinglow impact
Cruxal's analysis: Prism Medico and Pharmacy Limited has formally intimated the stock exchanges regarding a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Prism Medico and Pharmacy Ltd
Cruxal reads every Prism Medico and Pharmacy Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.